• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义原发性系统性硬化症心脏受累:范围文献综述。

Defining primary systemic sclerosis heart involvement: A scoping literature review.

机构信息

Department of Medicine at St Vincent's Hospital, University of Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065, Australia; Department of Rheumatology, St Vincent's Hospital, 41 Victoria Parade, Fitzroy, VIC 3065, Australia.

Department of Medicine at St Vincent's Hospital, University of Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065, Australia; Department of Cardiology, St Vincent's Hospital, 41 Victoria Parade, Fitzroy, VIC 3065, Australia.

出版信息

Semin Arthritis Rheum. 2019 Apr;48(5):874-887. doi: 10.1016/j.semarthrit.2018.07.008. Epub 2018 Jul 31.

DOI:10.1016/j.semarthrit.2018.07.008
PMID:30170705
Abstract

BACKGROUND

Clinically evident primary heart involvement due to systemic sclerosis (SHI) is considered a poor prognostic factor and is a leading cause of systemic sclerosis (SSc) related death. Yet, there remains no consensus definition of SHI and poor understanding of the natural history and risk factors for the development of SHI.

METHODS

We performed a scoping literature review of published articles with a primary focus of SHI to capture previously used definitions of SHI and items used to measure SHI. Any factors reported to be associated with an increased risk of SHI were recorded.

RESULTS

Of the 2436 records identified in a search of MEDLINE, EMBASE and PubMed databases, 295 were included in the final scoping review. Analysis of the literature revealed studies of variable quality, generally low patient numbers and highly heterogeneous definitions of SHI within studies. There is no clear consensus from the literature as to the scope of SHI and the prognostic significance of sub-clinical investigation abnormalities commonly detected.

CONCLUSION

The lack of a standardised definition of SHI remains a significant unmet need in SSc. The results of this review will assist in the development of consensus classification criteria to enable more accurate quantification of the burden of SHI, identification of factors associated with increased risk of developing SHI, and evaluation of the efficacy of any novel therapeutic strategies.

摘要

背景

由于系统性硬化症(SSc)引起的临床明显原发性心脏受累(SHI)被认为是预后不良的因素,也是系统性硬化症(SSc)相关死亡的主要原因。然而,目前尚没有 SHI 的共识定义,对 SHI 的自然史和危险因素也缺乏了解。

方法

我们对已发表的主要关注 SHI 的文献进行了范围广泛的文献回顾,以捕捉先前使用的 SHI 定义和用于测量 SHI 的项目。记录了报告与 SHI 风险增加相关的任何因素。

结果

在对 MEDLINE、EMBASE 和 PubMed 数据库的搜索中,共确定了 2436 条记录,其中 295 条记录纳入最终的范围综述。对文献的分析显示,研究质量参差不齐,患者数量普遍较少,研究中 SHI 的定义高度异质。文献中没有明确的共识,即 SHI 的范围以及通常检测到的亚临床异常的预后意义。

结论

缺乏 SHI 的标准化定义仍然是 SSc 中未满足的重要需求。本综述的结果将有助于制定共识分类标准,以便更准确地量化 SHI 的负担,确定与 SHI 风险增加相关的因素,并评估任何新的治疗策略的疗效。

相似文献

1
Defining primary systemic sclerosis heart involvement: A scoping literature review.定义原发性系统性硬化症心脏受累:范围文献综述。
Semin Arthritis Rheum. 2019 Apr;48(5):874-887. doi: 10.1016/j.semarthrit.2018.07.008. Epub 2018 Jul 31.
2
Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review.肌钙蛋白和 B 型利钠肽肽作为系统性硬化症心脏受累的诊断有用的生物标志物吗?系统文献复习。
Semin Arthritis Rheum. 2021 Feb;51(1):299-309. doi: 10.1016/j.semarthrit.2020.10.016. Epub 2020 Dec 29.
3
Heart involvement in patients with systemic sclerosis-what have we learned about it in the last 5 years.系统性硬化症患者的心脏受累——在过去的 5 年里,我们对此了解多少。
Rheumatol Int. 2024 Oct;44(10):1823-1836. doi: 10.1007/s00296-024-05699-x. Epub 2024 Aug 27.
4
Heart involvement in systemic sclerosis: emerging concepts.系统性硬化症的心脏受累:新出现的概念。
Curr Opin Rheumatol. 2024 Nov 1;36(6):393-400. doi: 10.1097/BOR.0000000000001038. Epub 2024 Aug 9.
5
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI).使用延迟增强心脏磁共振(CE-MRI)对系统性硬化症(SSc)的亚临床心脏受累进行早期评估。
Eur J Radiol. 2013 Jun;82(6):e268-73. doi: 10.1016/j.ejrad.2013.02.014. Epub 2013 Mar 16.
6
Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: A systematic review and meta-analysis.系统性硬化症中的心脏性猝死、心律失常和心电图异常:系统评价和荟萃分析。
Semin Arthritis Rheum. 2023 Oct;62:152229. doi: 10.1016/j.semarthrit.2023.152229. Epub 2023 Jun 19.
7
Systemic sclerosis and the heart.系统性硬化症与心脏。
Rheum Dis Clin North Am. 2014 Feb;40(1):87-102. doi: 10.1016/j.rdc.2013.10.007. Epub 2013 Nov 7.
8
Towards developing criteria for scleroderma renal crisis: A scoping review.旨在制定硬皮病肾危象标准:范围综述。
Autoimmun Rev. 2017 Apr;16(4):407-415. doi: 10.1016/j.autrev.2017.02.012. Epub 2017 Feb 14.
9
Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.系统性硬化症心脏并发症的认识、诊断和管理进展。
Curr Rheumatol Rep. 2019 Dec 7;21(12):68. doi: 10.1007/s11926-019-0867-0.
10
Cardiac complications of systemic sclerosis and management: recent progress.系统性硬皮病的心脏并发症及处理:最新进展。
Curr Opin Rheumatol. 2017 Nov;29(6):574-584. doi: 10.1097/BOR.0000000000000439.

引用本文的文献

1
Cardio-rheumatology: integrated care and the opportunities for personalized medicine.心血管风湿病学:综合治疗与个性化医疗的机遇
Ther Adv Musculoskelet Dis. 2025 Aug 1;17:1759720X251357188. doi: 10.1177/1759720X251357188. eCollection 2025.
2
Association of Systemic Sclerosis With Premature Ventricular Complexes and Cardiac Arrest: A National Inpatient Sample Analysis for 2021.系统性硬化症与室性早搏及心脏骤停的关联:2021年全国住院患者样本分析
Cureus. 2025 May 28;17(5):e84950. doi: 10.7759/cureus.84950. eCollection 2025 May.
3
The effect of hematopoietic stem cell transplantation on cardiac mechanics in systemic sclerosis.
造血干细胞移植对系统性硬化症心脏力学的影响。
Int J Cardiovasc Imaging. 2025 May;41(5):879-887. doi: 10.1007/s10554-025-03365-2. Epub 2025 Feb 26.
4
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort.欧洲硬皮病试验与研究队列中系统性硬化症原发性心脏受累及慢性心力衰竭的评估
J Am Heart Assoc. 2025 Mar 4;14(5):e036730. doi: 10.1161/JAHA.124.036730. Epub 2025 Feb 26.
5
Acute Myocarditis and Inflammatory Cardiomyopathies: Insights From Cardiac Magnetic Resonance Findings.急性心肌炎与炎症性心肌病:心脏磁共振成像结果的见解
Echocardiography. 2025 Feb;42(2):e70099. doi: 10.1111/echo.70099.
6
Cardiac Morpho-Functional Changes, Inflammation and Fibrosis in Systemic Sclerosis-A Pilot Study of a Tertiary Center Cohort.系统性硬化症中心脏形态功能变化、炎症及纤维化——一项三级中心队列的初步研究
Diagnostics (Basel). 2025 Feb 6;15(3):393. doi: 10.3390/diagnostics15030393.
7
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunities.系统性硬化症中的心脏受累:对知识空白与机遇的批判性综述
J Scleroderma Relat Disord. 2025 Jan 20:23971983241313096. doi: 10.1177/23971983241313096.
8
Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis.血管扩张剂药物与系统性硬化症的心脏相关结局:一项探索性分析。
RMD Open. 2024 Dec 9;10(4):e004918. doi: 10.1136/rmdopen-2024-004918.
9
Troponin I levels in systemic sclerosis patients with myocardial involvement.患有心肌受累的系统性硬化症患者的肌钙蛋白I水平。
J Scleroderma Relat Disord. 2024 Oct;9(3):185-191. doi: 10.1177/23971983241255550. Epub 2024 Jun 3.
10
Progression, Management, and Outcome of Aortic Valve Stenosis in Systemic Sclerosis: A Case Series.系统性硬化症中主动脉瓣狭窄的进展、管理及结局:病例系列
J Cardiovasc Dev Dis. 2024 Sep 4;11(9):274. doi: 10.3390/jcdd11090274.